Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-25 @ 4:41 AM
NCT ID:
NCT03620318
Eligibility Criteria:
Inclusion Criteria:
* Subject must have a serious life threatening cancer with FLT3/PDGFRa mutation or PDGFRa amplification who has exhausted all other treatment options
* Subject and their partner (if adults) must use 2 forms of contraception during study and for 3 months following last dose of study drug
Exclusion Criteria:
* Subject is eligible for enrollment in an ongoing clinical trial
* Subject has any condition which, in the investigator's opinion makes the subject unsuitable for participation
Sex:
ALL
Study:
NCT03620318
Study Brief:
Protocol Section:
NCT03620318